OsteoBiologics and US Biomaterials pool technologies
This article was originally published in Clinica
Executive Summary
Bioactive materials for reconstructive surgery and dentistry are the object of a licence agreement between US companies OsteoBiologics and US Biomaterials. By pooling USB's Bioglass technology and OBI's Immix scaffolds, the companies plan to develop products which will promote bone and cartilage repair following reconstructive surgery.